Pseudomonas aeruginosa serology and risk for re-isolation in the EPIC trial-Reference-Cited by-同舟云学术

Pseudomonas aeruginosa serology and risk for re-isolation in the EPIC trial

Published:2013-03 Issue:2 Volume:12 Page:147-153
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Anstead Michael,Heltshe Sonya L.,Khan Umer,Barbieri Joseph T.,Langkamp Markus,Döring Gerd,Dharia Shimoni,Gibson Ronald L.,Treggiari Miriam M.,Lymp James,Rosenfeld Margaret,Ramsey Bonnie

Funder

US Cystic Fibrosis Foundation

The National Institutes of Health

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology, and Child Health

Reference35 articles.

1. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis;Frederiksen;Pediatr Pulmonol,1997

2. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients;Taccetti;Eur Respir J,2005

3. Early intervention and prevention of lung disease in cystic fibrosis: a European consensus;Doring;J Cyst Fibros,2004

4. Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis;Rosenfeld;Pediatr Pulmonol,2001

5. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis;Burns;J Infect Dis,2001

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. S3-Leitlinie: Lungenerkrankung bei Mukoviszidose – Pseudomonas aeruginosa;Pneumologie;2024-02-13

2. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis;Cochrane Database of Systematic Reviews;2023-06-02

3. Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis;Cochrane Database of Systematic Reviews;2022-11-14

4. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis;Cochrane Database of Systematic Reviews;2022-08-01

5. Recent advances in the early treatment of cystic fibrosis: Bridging the gap to highly effective modulator therapy;Pediatric Pulmonology;2021-09-09